Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

THE absence of granulocytes from the peripheral blood is characterized by a clinical picture of overwhelming infection, involving especially the skin and mucous membranes. 1 Many cases are acute ...

X4 Pharmaceuticals has progressed significantly in its ongoing Phase 3 clinical trial, known as the 4WARD trial, targeting chronic neutropenia, aiming for full enrollment by the end of 2025 and ...

X4 Pharmaceuticals Inc (XFOR) reports significant advancements in Maverick 4 trials, international expansion, and financial ...

Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

The term idiopathic neutropenia describes a benign disorder of granulopoiesis characterized by the unexplained reduction in the absolute neutrophil count below the lower limit of the normal range ...

Neutropenia in individuals with a congenital defect or patients with cancer who are undergoing chemotherapy is generally treated with granulocyte colony-stimulating factor (G-CSF) to restore ...

Neutropenia, according to the Mayo Clinic, is a disease that occurs when "the body has too few neutrophils, a type of white blood cells." This is important because "all white blood cells help the ...

Rates of neutropenia, lymphopenia, and infections were lower in the patients receiving avacopan than those who were not.